6533b854fe1ef96bd12af959

RESEARCH PRODUCT

2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials

Antonio GalvanoDalila ScaturroViviana BazanGiulia Letizia MauroAntonio Russo

subject

Breast Cancer Denosumab Fracture HormoneProstate10.1016/j.jbo.2020.100295http://hdl.handle.net/10447/423059